Skip to main content

Market Overview

Monday's Top 7 Pre-Market Gainers

Share:
Monday's Top 7 Pre-Market Gainers
  • Adaptimmune Therapeutics PLC -ADR (NASDAQ: ADAP) traded up 34.89 percent after announcing positive data from Clinical Studies of NY-ESO-1 SPEAR T-Cells in Multiple Cancers at the 2016 ASCO.
  • Yingli Green Energy (NYSE: YGE) jumped 20.92 percent after seeing first positive quarterly net income since 2011.
  • Command Security Corporation (NYSE: MOC) was up 26.97 percent after it was awarded a 10-year Indefinite Quantity Airport Security Screening Services contract with the DHS Transportation Security Administration.
  • Concordia Healthcare Corp (NASDAQ: CXRX) rose 5.28 percent after Apollo Global Management said to be still in talks to acquire Concordia.

    Related Link: The Market In 5 Minutes: Float Like A Butterfly, Sting Like A Bee

  • Xcerra Corp (NASDAQ: XCRA) traded up 8.14 percent after reporting Q3 EPS of $0.00 vs estimates of $0.00 and $82.237 million sales vs. estimates of $81.4 million.
  • Array Biopharma Inc (NASDAQ: ARRY) was up 4.22 percent after reporting positive Phase 3 Beacon CRC trial results.
  • Juno Therapeutics (NASDAQ: JUNO) rose 5.92 percent following announcement of encouraging clinical data from CAR T cell product candidates.
  •  

    Related Articles (YGE + ADAP)

    View Comments and Join the Discussion!

    Posted-In: Biotech News Health Care Pre-Market Outlook Movers General

    Don't Miss Any Updates!
    News Directly in Your Inbox
    Subscribe to:
    Benzinga Premarket Activity
    Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
    Market in 5 Minutes
    Everything you need to know about the market - quick & easy.
    Fintech Focus
    A daily collection of all things fintech, interesting developments and market updates.
    SPAC
    Everything you need to know about the latest SPAC news.
    Thank You

    Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com